These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 29934995)

  • 21. SCN10A Mutation in a Patient with Erythromelalgia Enhances C-Fiber Activity Dependent Slowing.
    Kist AM; Sagafos D; Rush AM; Neacsu C; Eberhardt E; Schmidt R; Lunden LK; Ørstavik K; Kaluza L; Meents J; Zhang Z; Carr TH; Salter H; Malinowsky D; Wollberg P; Krupp J; Kleggetveit IP; Schmelz M; Jørum E; Lampert A; Namer B
    PLoS One; 2016; 11(9):e0161789. PubMed ID: 27598514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pain disorders and erythromelalgia caused by voltage-gated sodium channel mutations.
    Dabby R
    Curr Neurol Neurosci Rep; 2012 Feb; 12(1):76-83. PubMed ID: 21984269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Erythromelalgia: skin redness and pain].
    Dusch M; Schmelz M
    Schmerz; 2019 Oct; 33(5):475-490. PubMed ID: 31485751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel.
    Natkunarajah J; Atherton D; Elmslie F; Mansour S; Mortimer P
    Clin Exp Dermatol; 2009 Dec; 34(8):e640-2. PubMed ID: 19549232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of Nav1.7 in human nociceptors: insights from human induced pluripotent stem cell-derived sensory neurons of erythromelalgia patients.
    Meents JE; Bressan E; Sontag S; Foerster A; Hautvast P; Rösseler C; Hampl M; Schüler H; Goetzke R; Le TKC; Kleggetveit IP; Le Cann K; Kerth C; Rush AM; Rogers M; Kohl Z; Schmelz M; Wagner W; Jørum E; Namer B; Winner B; Zenke M; Lampert A
    Pain; 2019 Jun; 160(6):1327-1341. PubMed ID: 30720580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pain thresholds, supra-threshold pain and lidocaine sensitivity in patients with erythromelalgia, including the I848Tmutation in Na
    Helås T; Sagafos D; Kleggetveit IP; Quiding H; Jönsson B; Segerdahl M; Zhang Z; Salter H; Schmelz M; Jørum E
    Eur J Pain; 2017 Sep; 21(8):1316-1325. PubMed ID: 28418213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic, electrophysiological, and pathological studies on patients with SCN9A-related pain disorders.
    Yuan JH; Cheng X; Matsuura E; Higuchi Y; Ando M; Hashiguchi A; Yoshimura A; Nakachi R; Mine J; Taketani T; Maeda K; Kawakami S; Kira R; Tanaka S; Kanai K; Dib-Hajj F; Dib-Hajj SD; Waxman SG; Takashima H
    J Peripher Nerv Syst; 2023 Dec; 28(4):597-607. PubMed ID: 37555797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paroxysmal itch caused by gain-of-function Nav1.7 mutation.
    Devigili G; Eleopra R; Pierro T; Lombardi R; Rinaldo S; Lettieri C; Faber CG; Merkies ISJ; Waxman SG; Lauria G
    Pain; 2014 Sep; 155(9):1702-1707. PubMed ID: 24820863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gain-of-function mutations in sodium channel Na(v)1.9 in painful neuropathy.
    Huang J; Han C; Estacion M; Vasylyev D; Hoeijmakers JG; Gerrits MM; Tyrrell L; Lauria G; Faber CG; Dib-Hajj SD; Merkies IS; Waxman SG;
    Brain; 2014 Jun; 137(Pt 6):1627-42. PubMed ID: 24776970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nav1.7 mutations associated with paroxysmal extreme pain disorder, but not erythromelalgia, enhance Navbeta4 peptide-mediated resurgent sodium currents.
    Theile JW; Jarecki BW; Piekarz AD; Cummins TR
    J Physiol; 2011 Feb; 589(Pt 3):597-608. PubMed ID: 21115638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary erythromelalgia in a 12-year-old boy: positive response to sodium channel blockers despite negative SCN9A mutations.
    Jakob A; Creutzfeldt R; Staszewski O; Winterpacht A; Berner R; Hufnagel M
    Klin Padiatr; 2012 Sep; 224(5):309-12. PubMed ID: 22170168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Neuropathic pain associated with Nav1.7 mutations: clinical picture and treatment].
    Doppler K; Sommer C
    Nervenarzt; 2013 Dec; 84(12):1428-35. PubMed ID: 24202110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic-clamp analysis of wild-type human Nav1.7 and erythromelalgia mutant channel L858H.
    Vasylyev DV; Han C; Zhao P; Dib-Hajj S; Waxman SG
    J Neurophysiol; 2014 Apr; 111(7):1429-43. PubMed ID: 24401712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary erythermalgia as a sodium channelopathy: screening for SCN9A mutations: exclusion of a causal role of SCN10A and SCN11A.
    Drenth JP; Te Morsche RH; Mansour S; Mortimer PS
    Arch Dermatol; 2008 Mar; 144(3):320-4. PubMed ID: 18347287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Nav1.7 channel mutation associated with hereditary erythromelalgia contributes to neuronal hyperexcitability and displays reduced lidocaine sensitivity.
    Sheets PL; Jackson JO; Waxman SG; Dib-Hajj SD; Cummins TR
    J Physiol; 2007 Jun; 581(Pt 3):1019-31. PubMed ID: 17430993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paediatric hypertension-associated erythromelalgia responds to corticosteroids and is not associated with SCN9A mutations.
    Morales PS; Escobar RG; Lizama M; Aglony M; Salomon J; Drenth JP; Borzutzky A
    Rheumatology (Oxford); 2012 Dec; 51(12):2295-6. PubMed ID: 22718865
    [No Abstract]   [Full Text] [Related]  

  • 37. Insensitivity to Pain upon Adult-Onset Deletion of Nav1.7 or Its Blockade with Selective Inhibitors.
    Shields SD; Deng L; Reese RM; Dourado M; Tao J; Foreman O; Chang JH; Hackos DH
    J Neurosci; 2018 Nov; 38(47):10180-10201. PubMed ID: 30301756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Familial gain-of-function Na
    Han C; Yang Y; Te Morsche RH; Drenth JP; Politei JM; Waxman SG; Dib-Hajj SD
    J Neurol Neurosurg Psychiatry; 2017 Mar; 88(3):233-240. PubMed ID: 27503742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe case and literature review of primary erythromelalgia: novel SCN9A gene mutation.
    Skeik N; Rooke TW; Davis MD; Davis DM; Kalsi H; Kurth I; Richardson RC
    Vasc Med; 2012 Feb; 17(1):44-9. PubMed ID: 22033523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemical lumbar sympathectomy in the treatment of recalcitrant erythromelalgia.
    Wang WH; Zhang L; Dong GX; Sun TT; Lin ZM; Yang Y; Li X
    J Vasc Surg; 2018 Dec; 68(6):1897-1905. PubMed ID: 30126782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.